Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors
12019 / Pixabay

Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors

  The survival rates for infants and children with brain and spinal cord cancer has improved significantly over the past decades. However, a study published online in early August of…

Continue Reading Treatment for Childhood and Spinal Cord Cancer Linked to Lower Levels of Independence for Survivors
An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation
stevepb / Pixabay

An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation

The US FDA has awarded Breakthrough Therapy Designation to encorafenib (braftoviTM) combined with binimetinib (mektovi®) and cetuximab for use as an investigational (not FDA-approved) treatment of BRAFV600E–mutant metastatic colorectal cancer.…

Continue Reading An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation

This SLP’s Mission to Expand Resources for Those with ALS, Muscular Dystrophy, and More

  According to ASHA.org, when Tiffany Turner graduated, she set out to expand opportunities for fellow speech language pathologists like herself. Turner saw a great need in her community for…

Continue Reading This SLP’s Mission to Expand Resources for Those with ALS, Muscular Dystrophy, and More

The FDA Have Granted Priority Review to Elzonris for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

  A Biologics License Application for ElzonrisTM (also known as tagraxofusp and SL-401) for the treatment of blastic plasmacytoid dendritic cell neoplasm has been accepted for filing by the United States FDA.…

Continue Reading The FDA Have Granted Priority Review to Elzonris for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV
Rainer_Maiores / Pixabay

Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV

Researchers are exploring a new diagnostic method that could be applied to newborn screening for certain inherited diseases and monitoring of HIV patients. For more detailed information, you can click…

Continue Reading Epigenetic Technology Could Become Useful in Newborn Screening for Primary Immunodeficiency and Monitoring HIV

Results from First Study on Patient-To-Patient Connectivity in Those with FCS

  According to DAIC, Akcea Therapeutics Inc., has recently announced their publication of results from their study analyzing patient-to-patient connectivity towards the management of the rare disease familial chylomicronemia syndrome (FCS).…

Continue Reading Results from First Study on Patient-To-Patient Connectivity in Those with FCS
At Just Weeks Old, a Baby From Auckland is Diagnosed With Aicardi Syndrome and Opsoclonus Myoclonus Syndrome
https://pixabay.com/en/baby-care-child-cute-hand-face-20339/

At Just Weeks Old, a Baby From Auckland is Diagnosed With Aicardi Syndrome and Opsoclonus Myoclonus Syndrome

According to a story from stuff.co.nz, a baby from Auckland has been diagnosed with two extremely rare disorders that only occur in one in every 10 million people. Her name…

Continue Reading At Just Weeks Old, a Baby From Auckland is Diagnosed With Aicardi Syndrome and Opsoclonus Myoclonus Syndrome
The FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma
Bru-nO / Pixabay

The FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma

9% Copyscape An investigational drug called CLR 131 has received Rare Pediatric Disease Designation from the US FDA for the treatment of Ewing’s sarcoma. The source press release can be…

Continue Reading The FDA Has Granted Rare Pediatric Disease Designation to an Investigational Drug For the Treatment of Ewing’s Sarcoma
A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say
felixioncool / Pixabay

A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say

A research team led by scientists from the Beth Israel Deaconess Medical Center (BIDMC) have found that arsenic, in combination with the drug all-trans retinoic acid (ATRA), may have the potential…

Continue Reading A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say
Orthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study
ashokorg0 / Pixabay

Orthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study

A recently published study in the Journal of Biosciences and Medicines has concluded that orthoses may help to improve the gait and balance of patients with Charcot-Marie-Tooth disease. Orthoses are…

Continue Reading Orthoses Could Help to Improve Gait and Balance for Patients with Charcot-Marie-Tooth Disease, According to a Recent Study